Skip to main content
Adastra Holdings logo

Adastra Holdings — Investor Relations & Filings

Ticker · XTRX ISIN · CA00654D2095 LEI · 549300SKMLMH3FJ3AF32 CSE Manufacturing
Filings indexed 489 across all filing types
Latest filing 2022-05-28 Regulatory Filings
Country CA Canada
Listing CSE XTRX

About Adastra Holdings

https://adastraholdings.ca/

Adastra Holdings is a manufacturer and supplier of ethnobotanical and cannabis products for the lawful adult-use and medical markets. The company specializes in the extraction and processing of cannabis, offering a portfolio that includes concentrates, vape pens, wax, resin, and infused pre-rolls. Adastra manufactures products for its proprietary brands, such as Phyto Extractions and Endgame Extracts, and provides co-manufacturing services for partners. A core operational advantage is the co-location of Adastra Labs with Chemia Analytics, an in-house licensed analytical testing and consulting laboratory. This integrated facility ensures rigorous quality control, compliance, and efficient product development, emphasizing a scientific and refined approach to extraction methodologies.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-05-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of Adastra Holdings Ltd. It certifies the review and fair presentation of the interim filings for the period ended March 31, 2022. The document is a certification letter, not the interim report itself, and it explicitly states it is a certificate under National Instrument 52-109. The document length is short (3032 characters) and contains no actual financial data or statements, only attestation. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself.
2022-05-28 English
Interim MD&A - English.pdf
Regulatory Filings
2022-05-28 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-05-28 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a form for shareholders to request receiving Interim Financial Statements and/or Annual Financial Statements by mail. It does not contain any actual financial data, analysis, or report content. It is essentially a mailing request form related to financial reports, not the reports themselves. The document length is short (1304 characters), and it serves as a communication or request form rather than a report or announcement of results. Therefore, it does not fit categories like 10-K (Annual Report) or IR (Interim Report). It is also not an announcement of report publication but a request form. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2022-05-26 English
Other.pdf
AGM Information Classification · 95% confidence The document text includes references to an Annual Meeting scheduled for June 23, 2022, with details about director appointments, auditor appointment, and voting recommendations. The content is focused on meeting logistics and voting items rather than financial data or detailed reports. The document length is short (2632 characters), and it appears to be materials or information related to the Annual General Meeting (AGM). There is no indication of full financial statements or detailed presentations, so it is not an Annual Report or Interim Report. The presence of voting recommendations and meeting agenda aligns with AGM Information filings.
2022-05-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.